Abstract
Introduction
Personalized Medicine (PM) holds great potential in healthcare. A few existing surveys have investigated awareness, understanding, and interest regarding PM in the general public; however, studies investigating college students’ opinions about PM are lacking. This study aimed to evaluate the college student’s awareness, understanding, and interest in PM, and their opinion was also analyzed by their gender and major.
Methods
The study samples were undergraduate students enrolled at the University of Nevada, Las Vegas (UNLV). A web-based survey with 42 questions was emailed to all UNLV undergraduate students. Overall survey results were analyzed by gender and each student’s major. A chi-square test evaluated the significant association between responses to questions with regard to gender or major.
Results
Among the participants, 1225 students completed the survey. This survey found that most college students had a neutral attitude to PM and were not entirely familiar with this field. For example, most students (57.6%) had a “neutral” attitude toward PM. In addition, 77.6% of students never received any personal genetic testing. More than 80% of students thought “interests” was the most important factor in using PM, and 50% of respondents chose “somewhat likely” to the recommendation about PM from the doctor. Also of importance was the finding that a significant association between the most important factor of using PM and gender was observed (p = 0.04), and the associations between a student’s major affected his or her reaction to PM, how well informed she or he was about PM, his or her attitude toward a doctor’s recommendation about using PM were all significant (all participant’s p<0.004).
Conclusion
UNLV undergraduate students had a neutral attitude to PM and were not entirely familiar with this field.
Publisher
Public Library of Science (PLoS)
Reference26 articles.
1. Personalized medicine: motivation, challenges, and progress;LH Goetz;Fertil Steril,2018
2. Future Promises and Concerns of Ubiquitous Next-Generation Sequencing.;WR McCombie;Cold Spring Harb Perspect Med,2019
3. 23andMe. Power of one million 2015 [cited 2022 5/10]. Available from: https://blog.23andme.com/news/one-in-a-million/.
4. Optimizing Precision Medicine for Public Health.;GA Bilkey;Frontiers in Public Health.,2019
5. Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival;CK Lee;Journal of the National Cancer Institute,2017